Ann: Admedus Appoints Wayne Paterson as CEO, page-13

This is an incredible announcement and the best news Admedus shareholders could have hoped for. Words cannot describe what an incredible leader/operator Wayne Paterson is although I think the following numbers from his past history at Merck give an indication of what kind of results he can achieve and the kind of results Admedus shareholders can look forward to....

From 2005 to 2013, he held senior positions at Merck Kgaa. In his most recent role as President of Europe, Canada and Australia, he managed over $3 billion in sales with an operational budget of $500 million and was a member of the Global Executive Board. Paterson also held the position of Global Director (Executive Vice President) of Cardio Metabolic Care and General Medicine, with revenue responsibility of $1.5 billion, and was responsible for all aspects of company strategy, including manufacturing strategies, commercial operations and budgets. Between 2010 and 2012, he was President and CEO of Emerging Markets including Russia, China, India and Brazil (as well as 40 other countries), and was a member of the Executive Board.

As President of Merck’s Japanese operations between 2007 and 2010 in Tokyo, he grew the business at a CAGR of 93% against the market growth of 3%.